Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndrome

Patients with metabolic syndrome are at a higher risk of nonalcoholic fatty liver disease (NAFLD) and liver fibrosis than the general population. Still, accessibility of screening method for NAFLD with significant fibrosis, such as transient elastography (FibroScan) are limited in some settings. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kositamongkol, Chayanis, Charernboon, Thammanard, Chaisathaphol, Thanet, Washirasaksiri, Chaiwat, Auesomwang, Chonticha, Sitasuwan, Tullaya, Charatcharoenwitthaya, Phunchai, Phisalprapa, Pochamana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568356/
https://www.ncbi.nlm.nih.gov/pubmed/34871234
http://dx.doi.org/10.1097/MD.0000000000027640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568356/
https://www.ncbi.nlm.nih.gov/pubmed/34871234
http://dx.doi.org/10.1097/MD.0000000000027640

Ejemplares similares